No comments yet

Santhera to Discontinue Sale of Catena in Canada

February 27, 2013: Santhera Pharmaceuticals announced the voluntary withdrawal of Catena® from the Canadian market. This decision follows review of additional data from clinical trials in patients with Friedreich’s Ataxia, and subsequent consultation with Health Canada.




Post a comment